Ocugen, Inc. (OCGN)
0.7803
-0.03
(-4.10%)
USD |
NASDAQ |
Oct 16, 16:00
0.7996
+0.02
(+2.47%)
After-Hours: 20:00
Ocugen Free Cash Flow : -61.02M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.02M |
| March 31, 2026 | -59.58M |
| December 31, 2025 | -57.15M |
| September 30, 2025 | -53.53M |
| June 30, 2025 | -52.30M |
| March 31, 2025 | -51.95M |
| December 31, 2024 | -45.53M |
| September 30, 2024 | -49.17M |
| June 30, 2024 | -54.47M |
| March 31, 2024 | -65.62M |
| December 31, 2023 | -72.53M |
| September 30, 2023 | -77.44M |
| June 30, 2023 | -75.52M |
| March 31, 2023 | -69.10M |
| December 31, 2022 | -64.54M |
| September 30, 2022 | -58.47M |
| June 30, 2022 | -51.72M |
| March 31, 2022 | -58.62M |
| December 31, 2021 | -48.88M |
| September 30, 2021 | -40.54M |
| June 30, 2021 | -34.82M |
| March 31, 2021 | -15.82M |
| December 31, 2020 | -15.02M |
| September 30, 2020 | -19.25M |
| June 30, 2020 | -21.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -21.31M |
| December 31, 2019 | -19.25M |
| September 30, 2019 | -13.27M |
| June 30, 2019 | -13.08M |
| March 31, 2019 | -16.42M |
| December 31, 2018 | -11.71M |
| September 30, 2018 | -13.38M |
| June 30, 2018 | -14.91M |
| March 31, 2018 | -13.88M |
| December 31, 2017 | -23.30M |
| September 30, 2017 | -24.73M |
| June 30, 2017 | -24.41M |
| March 31, 2017 | -25.56M |
| December 31, 2016 | -26.06M |
| September 30, 2016 | -27.29M |
| June 30, 2016 | -29.21M |
| March 31, 2016 | -30.25M |
| December 31, 2015 | -31.98M |
| September 30, 2015 | -31.74M |
| June 30, 2015 | -28.54M |
| March 31, 2015 | -26.19M |
| December 31, 2014 | -21.73M |
| September 30, 2014 | -20.03M |
| June 30, 2014 | -19.83M |
| March 31, 2014 | -18.22M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Anika Therapeutics, Inc. | 0.562M |
| Gilead Sciences, Inc. | 12.94B |
| MannKind Corp. | -18.30M |
| Nektar Therapeutics | -234.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.20M |
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | 80.37M |
| Free Cash Flow Per Share (Quarterly) | -0.0361 |
| Free Cash Flow to Equity (Quarterly) | -66.91M |
| Free Cash Flow to Firm (Quarterly) | -7.743M |
| Free Cash Flow Yield | -24.39% |